3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
25
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Myelodysplastic Syndromes
16
Hodgkin Disease
13
Lymphoma, Non-Hodgkin
11
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma
8
Leukemia, Biphenotypic, Acute
8
Leukemia
8
Burkitt Lymphoma
7
Breast Neoplasms
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neuroblastoma
5
Neoplasms
5
Multiple Myeloma
5
Lymphoma, Mantle-Cell
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hematologic Neoplasms
5
Triple Negative Breast Neoplasms
4
Sarcoma
4
Rhabdomyosarcoma
4
Medulloblastoma
4
Lymphoma, Follicular
4
Anemia, Refractory, with Excess of Blasts
4
Leukemia, Myelomonocytic, Chronic
3
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Myeloproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Interventions
Cisplatin
7
Gemcitabine
6
pembrolizumab
4
Radiotherapy, Intensity-Modulated
4
toripalimab
2
Bevacizumab
2
tocilizumab
1
tislelizumab
1
spartalizumab
1
penpulimab
1
atezolizumab
1
Vitamin D
1
Tablets
1
Surveys and Questionnaires
1
Phantoms, Imaging
1
Oral Hygiene
1
Observation
1
Magnetic Resonance Spectroscopy
1
Immunotherapy
1
Immunohistochemistry
1
Immunoglobulin G
1
Fluorouracil
1
Disulfides
1
Dexamethasone
1
Chemoradiotherapy
1
Cetuximab
1
Carboplatin
1
Capecitabine
1
Blood Specimen Collection
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Neoplasms
×
Filgrastim
×
1 year
×
Clear all
No trials found.